TrialNature communications2026

Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study.

Mrinal Gounder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.